Own report: This time the vaccine is also a beacon of hope for children. Bharat Biotech allowed covaxin trials in the second and third phases on 2 to 18 year olds. The expert committee of the Central Drug Standards Control Organization (CDSCO) (SEC) gave this permission on Tuesday. The trial will be conducted in the second and third stages to test the effectiveness and response of this vaccine in children. This trial will start soon. If all goes well, a dose of covacin can be given to children at least 2 years old.

Read more: Now more fear with the Indian Corona variant! Searched from 44 countriesWHO

It is to be noted that a section of the medical community has already expressed the fear that the children will be more infected in the third wave of Corona. India Biotech was allowed to conduct covacin trials on children soon after the report was released. The tests will be performed on at least 525 people at the AIIMS Hospital in Delhi and Patna and at the Meditrina Institute in Nagpur. Earlier, in response to Bharat Biotech’s proposal, the company was directed to submit rules on clinical trials at a meeting with an expert committee on February 24. And that proposal was completely accepted this time.